New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 1, 2013
11:24 EDTTHRX, TLM, BPI, SHSHigh option volume stocks: THRX TLM MNX BPI SHS
News For THRX;TLM;BPI;SHS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 24, 2014
10:29 EDTTLMOptions with decreasing implied volatility
Subscribe for More Information
06:11 EDTTLMStocks with implied volatility above IV index mean; AMZN TLM
Stocks with implied volatility above IV index mean; Amazon.com (AMZN) 41, Talisman Energy (TLM) 83 according to iVolatility.
October 23, 2014
05:56 EDTTLMStocks with implied volatility above IV index mean; NQ TLM
Stocks with implied volatility above IV index mean; NQ Mobile (NQ) 184, Talisman Energy (TLM) 83 according to iVolatility.
October 22, 2014
14:43 EDTTHRXTheravance drops after partner announces restructuring, posts abstracts
Shares of Theravance, (THRX) a biopharmaceutical company that has economic ties to GlaxoSmithKline (GSK), are lower in afternoon trading after Glaxo reported restructuring plans. Additionally, Theravance disclosed last night that GSK is scheduled to present data from Phase 3 studies at an upcoming medical conference. CHEST 2014 in Austin, Texas, to be held from October 25-30. WHAT'S NEW: Earlier today, GlaxoSmithKline announced it intends to refocus its global pharmaceuticals business and cost base following the divestment of its oncology products and the changed dynamics now faced in the U.S. respiratory market. Theravance has strategic alliances with GlaxoSmithKline in respiratory products. Also, Theravance disclosed last night that Glaxo is scheduled to present data from Phase 3 studies at CHEST 2014, which is being held from October 25-30. Umeclidinium/Vilanterol, a once-daily combination treatment comprising two bronchodilators in Theravance's ELLIPTA inhaler, and Fluticasone Furoate/Vilanterol, a once-daily combination of a LABA and inhaled corticosteroid, have been developed under a collaboration pact between Glaxo and Theravance. Abstracts of the planned oral presentations can be found in the CHEST Journal, Theravance noted in its filing. PRICE ACTION: In afternoon trading, shares of Theravance fell 10.25% to $16.73.
11:14 EDTTHRXHigh option volume stocks
Subscribe for More Information
06:06 EDTTLMStocks with implied volatility above IV index mean; NQ TLM
Stocks with implied volatility above IV index mean; NQ Mobile (NQ) 178, Talisman Energy (TLM) 89 according to iVolatility.
October 21, 2014
12:37 EDTTLMOptions with increasing implied volatility
Subscribe for More Information
10:00 EDTTLMOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:31 EDTTLMTalisman Energy upgraded to Speculative Buy from Neutral at Global Hunter
Subscribe for More Information
05:51 EDTTLMStocks with implied volatility movement; TLM BBRY
Subscribe for More Information
October 20, 2014
13:40 EDTTLMOptions with increasing implied volatility
Subscribe for More Information
13:24 EDTTLMTalisman Energy volatility elevated
Subscribe for More Information
05:49 EDTTLMStocks with implied volatility movement; TLM NUAN
Subscribe for More Information
October 17, 2014
05:25 EDTTHRXTheravance announces positive Anoro Ellipta study data published
Subscribe for More Information
October 15, 2014
07:07 EDTBPIFor profit education positive catalysts outweigh negative, says Wells Fargo
Wells Fargo expects for-profit education stocks to benefit from improved hiring trends and a sale by Corinthian of its assets that, according t othe firm ,would set a valuation floor for the sector. The firm continues to believe that the final gainful employment rule will be neutral to positive for the group. Wells favors the option value on the long side for the sector. Publicly traded companies in the space include American Public Education (APEI), Apollo Education (APOL), Bridgepoint Education (BPI), Career Education (CECO), Corinthian Colleges (COCO), DeVry (DV), Grand Canyon (LOPE), ITT Educational (ESI) and Strayer (STRA).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use